帝国集团环球控股(00776.HK)与一家日本游戏公司订立游戏独家代理许可协议
格隆汇8月18日丨帝国集团环球控股(00776.HK)发布公告,于2020年8月18日,获许可方七元素游戏有限公司(公司全资附属公司)与许可方Asobimo, Inc.订立许可协议,据此,获许可方获授权担任独家代理,在指定地区营销、发行、营运及分销手机游戏的独家代理,自签订许可协议日期起计初步为期三年,并可于期满时续期。
获许可方须于商业化推出日期后12个月内透过在指定地区实施其线上或线下营销计划(包括广告、共同合作、新闻发布会或其他非免费增值营销活动),投资最少金额150万美元以推广手机游戏。
许可方为一家于日本东京注册成立的公司,主要从事网络游戏的开发及营运。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.